Virtual Reality for the Management of Pain and Anxiety for Outpatient Interventional Radiology Procedures
1 other identifier
interventional
107
1 country
1
Brief Summary
This study explores the use of virtual reality (VR) to reduce pain and anxiety during thyroid biopsies and PICC line insertions under local anesthesia. One group experienced the procedure with VR, while the other group did not. Participants completed questionnaires before and after the surgery to measure pain and anxiety levels. The main goal is to observe if VR can significantly decrease pain and anxiety during these procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable pain
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 2, 2022
CompletedFirst Submitted
Initial submission to the registry
November 12, 2023
CompletedFirst Posted
Study publicly available on registry
November 30, 2023
CompletedNovember 30, 2023
November 1, 2023
1.1 years
November 12, 2023
November 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pain (VAS)
Pre-procedure pain assessments were obtained using a Visual Analog Scale (VAS) corresponding to the patient's expected level of pain during each procedure prior to randomization to treatment or control. VAS scale was measured in mm, 0mm indicating "no pain", 100mm indicating "worst pain." Following each procedure, participants completed a self-reported survey indicating actual pain felt during procedure on VAS scale.
Immediately prior to and after procedure
Anxiety (VAS)
Pre-procedure anxiety assessments were administered using a VAS scale to indicate the patient's level of anxiety prior to randomization to treatment or control. Similar to pain, VAS anxiety scale was measured in mm, 0mm indicating "no anxiety", 100mm indicating "worst anxiety." Following each procedure, participants completed a self-reported survey indicating actual level anxiety experienced during the procedure on VAS scale.
Immediately prior to and after procedure
Secondary Outcomes (5)
Pulse Rate (bpm)
Three times during procedure
Systolic Blood Pressure (mmHg)
Three times during procedure
Diastolic Blood Pressure (mmHg)
Three times during procedure
Procedure Length
Duration of procedure
Lidocaine Administered
Immediately after procedure
Study Arms (4)
Thyroid Biopsy (Control)
ACTIVE COMPARATORPatients within this arm received standard procedure thyroid biopsies without virtual reality.
Thyroid Biopsy (Virtual Reality)
EXPERIMENTALPatients within this arm received standard procedure thyroid biopsies with virtual reality for the length of the procedure.
PICC (Control)
ACTIVE COMPARATORPatients within this arm received standard procedure PICC placements without virtual reality.
PICC (Virtual Reality)
EXPERIMENTALPatients within this arm received standard procedure PICC placements with virtual reality for the length of the procedure.
Interventions
Study participants assigned to the VR intervention group were fitted with an HP Reverb G2 Head Mounted Display (HMD) and a wireless mouse prior to preparation for procedure. One virtual environment was utilized, integrating passive and active participant input via gyroscopic motion detection and computer mouse input.
In this procedure the patient lies down on a bed with their neck tilted back to reveal the thyroid gland. The doctor cleans the skin over the nodule and numbs it with a local anesthetic. The doctor will then use an ultrasound device to visualize the nodule and guide a needle to obtain cells through the syringe. This process may be repeated several times to retrieve adequate tissue for analysis.
In this procedure the patient lies down on a bed and has their arm cleaned and then numbed with a local anesthetic. The doctor then uses an ultrasound to locate a suitable vein in the arm, typically above the elbow. The physician then makes a small incision in the skin and inserts a needle into the vein, followed by guidance of the Peripherally Inserted Central Catheter (PICC) through the needle until it reaches a large vein near the heart. The final position is confirmed by X-ray and the PICC line is secured at the site of insertion.
Eligibility Criteria
You may qualify if:
- Age over 18
- Scheduled to receive Fine-Needle Aspiration (FNA) Thyroid Biopsy
- Scheduled to receive Peripherally Inserted Central Catheters (PICC)
You may not qualify if:
- Declining to participate
- Inability to provide consent
- Emergency procedures
- Administration of general anesthesia/moderate sedation
- Visual or hearing deficits
- Pregnancy
- Current prisoner status
- Nerve or sensory deficits over area of procedure
- COVID-19 positive status
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Temple University Hospital
Philadelphia, Pennsylvania, 19140, United States
Related Publications (2)
Mallari B, Spaeth EK, Goh H, Boyd BS. Virtual reality as an analgesic for acute and chronic pain in adults: a systematic review and meta-analysis. J Pain Res. 2019 Jul 3;12:2053-2085. doi: 10.2147/JPR.S200498. eCollection 2019.
PMID: 31308733RESULTGold JI, Kim SH, Kant AJ, Joseph MH, Rizzo AS. Effectiveness of virtual reality for pediatric pain distraction during i.v. placement. Cyberpsychol Behav. 2006 Apr;9(2):207-12. doi: 10.1089/cpb.2006.9.207.
PMID: 16640481RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hillel Maresky, M.D.
Temple University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 12, 2023
First Posted
November 30, 2023
Study Start
June 10, 2021
Primary Completion
August 2, 2022
Study Completion
August 2, 2022
Last Updated
November 30, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data requests can be submitted starting 6 months after article publication and the data will be made accessible for up to 5 years.
- Access Criteria
- Access to trial IPD can be requested by qualified research engaging in independent scientific research, and will be provided following review and approval of a research proposal and a data sharing agreement.
All IPD that underlie the results reported in the main publication, including demographics, outcomes, and adverse events, will be shared.